Despite active clinical use of statins and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, unfortunately, up to now, there are no effective drugs or treatments completely preventing or reversing atherosclerosis development, which proves the absence of a clear understanding of the pathogenesis of this disease. This evidence concerns the gene PCSK9 and atherosclerosis.